Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1899 1
1946 1
1947 1
1968 1
1970 1
1975 3
1976 3
1977 4
1978 3
1979 4
1980 2
1981 2
1982 2
1983 5
1984 2
1985 2
1986 1
1987 5
1988 1
1989 8
1990 6
1991 3
1992 7
1993 2
1994 7
1995 12
1996 8
1997 11
1998 10
1999 10
2000 27
2001 26
2002 28
2003 36
2004 46
2005 36
2006 39
2007 33
2008 45
2009 43
2010 53
2011 41
2012 48
2013 52
2014 41
2015 46
2016 50
2017 41
2018 37
2019 41
2020 44
2021 57
2022 48
2023 53
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

1,050 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. Among authors: bird s. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Clinical Trial.
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775.
Makker V, Colombo N, Casado Herráez A, Monk BJ, Mackay H, Santin AD, Miller DS, Moore RG, Baron-Hay S, Ray-Coquard I, Ushijima K, Yonemori K, Kim YM, Guerra Alia EM, Sanli UA, Bird S, Orlowski R, McKenzie J, Okpara C, Barresi G, Lorusso D. Makker V, et al. Among authors: bird s. J Clin Oncol. 2023 Jun 1;41(16):2904-2910. doi: 10.1200/JCO.22.02152. Epub 2023 Apr 14. J Clin Oncol. 2023. PMID: 37058687 Free PMC article. Clinical Trial.
Mohammed's case.
Bird S. Bird S. Aust Fam Physician. 2014 May;43(5):331-2. Aust Fam Physician. 2014. PMID: 24791779 Free article. No abstract available.
Scotland's National Naloxone Programme.
Bird SM, McAuley A. Bird SM, et al. Lancet. 2019 Jan 26;393(10169):316-318. doi: 10.1016/S0140-6736(18)33065-4. Lancet. 2019. PMID: 30696566 No abstract available.
Acute Manifestations of Neuromuscular Disease.
Edmundson C, Bird SJ. Edmundson C, et al. Among authors: bird sj. Semin Neurol. 2019 Feb;39(1):115-124. doi: 10.1055/s-0038-1676838. Epub 2019 Feb 11. Semin Neurol. 2019. PMID: 30743297 Review.
Multiple myeloma: an overview of management.
Bird SA, Boyd K. Bird SA, et al. Palliat Care Soc Pract. 2019 Oct 9;13:1178224219868235. doi: 10.1177/1178224219868235. eCollection 2019. Palliat Care Soc Pract. 2019. PMID: 32215370 Free PMC article. Review.
1,050 results